1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Antibody-mediated Rejection: new trials by email Literature Review of Antibody-mediated Rejection trials Research Report on Antibody-mediated Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation Eculizumab - Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant | Phase 3 | Completed | Cedars-Sinai Medical Center | 36 | 2012-11-01 | 2021-05-03 |
Complement Component 3 Deficiency, Autosomal Recessive (1) · Ventricular Dysfunction, Left (1)
Cardiovascular Diseases (1) · Heart Diseases (1) · Ventricular Dysfunction (1)
eculizumab (1)
Cedars-Sinai Medical Center (1)
United States (1)
Jignesh Patel, M.D., Ph.D. (1)